{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:47:35Z","timestamp":1785894455637,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017981","name":"Sysmex Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007331","name":"Aichi Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ekir.2026.106549","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:10:15Z","timestamp":1776755415000},"page":"106549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary Microcholesterol and Adverse Kidney Outcomes in CKD"],"prefix":"10.1016","volume":"11","author":[{"given":"Hirotaka","family":"Furuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanaka","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshiro","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106549_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fphar.2018.00939","article-title":"Bile acid synthesis: from nature to the chemical modification and synthesis and their applications as drugs and nutrients","volume":"9","author":"Sarenac","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ekir.2026.106549_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/srep33756","article-title":"Differential human urinary lipid profiles using various lipid-extraction protocols: MALDI-TOF and LIFT-TOF\/TOF analyses","volume":"6","author":"Tipthara","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106549_bib3","first-page":"iv","article-title":"Urinary cholesterol excretion in cancer and control subjects","volume":"44","author":"Burchell","year":"1949","journal-title":"Biochem J"},{"key":"10.1016\/j.ekir.2026.106549_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106549_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0000000000000217","article-title":"Kidneys: key modulators of high-density lipoprotein levels and function","volume":"25","author":"Yang","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2026.106549_bib6","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI105639","article-title":"Qualitative and quantitative analysis of urinary lipids in the nephrotic syndrome","volume":"46","author":"Klahr","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106549_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/ki.1994.400","article-title":"Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells","volume":"46","author":"Ong","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106549_bib8","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1523-1755.2002.00618.x","article-title":"Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage","volume":"62","author":"Kamijo","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106549_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jdiacomp.2017.04.024","article-title":"Urinary lysophopholipids are increased in diabetic patients with nephropathy","volume":"31","author":"Saulnier-Blache","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ekir.2026.106549_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.101009","article-title":"Plasma and urine metabolites associated with nondiabetic chronic kidney disease: the HELIUS study","volume":"7","author":"Mosterd","year":"2025","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2026.106549_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1681\/ASN.2022010098","article-title":"Systematic review and meta-analysis of plasma and urine biomarkers for CKD outcomes","volume":"33","author":"Liu","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106549_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.ajkd.2024.03.028","article-title":"Associations of urine and plasma metabolites with kidney failure and death in a chronic kidney disease cohort","volume":"84","author":"Steinbrenner","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106549_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/tpj.2017.24","article-title":"Urinary lipidomics: evidence for multiple sources and sexual dimorphism in healthy individuals","volume":"18","author":"Graessler","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ekir.2026.106549_bib14","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1111\/j.1523-1755.2004.66026.x","article-title":"Predictive value of urinary microcholesterol (mCHO) levels in patients with progressive glomerular disease","volume":"66","author":"Hotta","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106549_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/clinchem\/48.5.737","article-title":"Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum","volume":"48","author":"Kishi","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.ekir.2026.106549_bib16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106549_bib17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","article-title":"Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease","volume":"2","author":"Moorhead","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.106549_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11906-012-0250-2","article-title":"Lipid nephrotoxicity: new concept for an old disease","volume":"14","author":"Gyebi","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ekir.2026.106549_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106549_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(85)90181-9","article-title":"Lipoprotein distribution and composition in the human nephrotic syndrome","volume":"54","author":"Muls","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2026.106549_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-119-4-199308150-00002","article-title":"Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome","volume":"119","author":"Wanner","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.106549_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ekir.2026.106549_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106549_bib24","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1172\/JCI79641","article-title":"Albumin-associated free fatty acids induce macropinocytosis in podocytes","volume":"125","author":"Chung","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106549_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrneph.2015.76","article-title":"Podocyte biology: free fatty acid-induced macropinocytosis in podocytes","volume":"11","author":"Allison","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106549_bib26","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3390\/ijms17111868","article-title":"Stearoyl-CoA desaturase-1 protects cells against lipotoxicity-mediated apoptosis in proximal tubular cells","volume":"17","author":"Iwai","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106549_bib27","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00223.2015","article-title":"Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney","volume":"310","author":"Li","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106549_bib28","first-page":"10653","article-title":"Fenofibrate, a PPARalpha agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB","volume":"8","author":"Zuo","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ekir.2026.106549_bib29","doi-asserted-by":"crossref","first-page":"F896","DOI":"10.1152\/ajprenal.00484.2013","article-title":"Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis","volume":"306","author":"Ruggiero","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106549_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ekir.2016.08.007","article-title":"Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort","volume":"1","author":"Afshinnia","year":"2016","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.106549_bib31","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/s41467-023-41642-7","article-title":"Proteomics of CKD progression in the chronic renal insufficiency cohort","volume":"14","author":"Dubin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2026.106549_bib32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926027816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926027816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:08:48Z","timestamp":1785892128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926027816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2468024926027816"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106549","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary Microcholesterol and Adverse Kidney Outcomes in CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106549"}}